02 June, 2017
591,267 shares of the stock were exchanged. The stock, after opening at $1.25, touched a high of $1.66 before paring much of its gains. About shares traded. Aecom (NYSE:ACM) has risen 3.75% since June 2, 2016 and is uptrending. Therefore 93% are positive. PDL BioPharma had 6 analyst reports since October 16, 2015 according to SRatingsIntel. Finally, Cowen and Company reaffirmed a "hold" rating on shares of PDL BioPharma in a report on Wednesday, May 3rd. The firm has "Sector Perform" rating given on Tuesday, February 2 by RBC Capital Markets. The company was maintained on Tuesday, February 23 by RBC Capital Markets.
Analysts on average have given a price target of $3.25 to PDL BioPharma, Inc.
Virginia Retirement Et Al has invested 0% in PDL BioPharma Inc (NASDAQ:PDLI). The rating was maintained by JP Morgan with "Overweight" on Thursday, April 7.
Shares of PDL BioPharma Inc (NASDAQ:PDLI) opened at 2.39 on Thursday. The stock, after opening at $2.39, hit $2.39 through the close by scoring 0%.
The Stock had a 2 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2 and 1 respectively. It has underperformed by 42.73% the S&P500. (PDLI) may be overvalued, however, this can also depend upon the situation of the market; if the market is strong then it could suggest that PDL BioPharma, Inc.
About PDL BioPharma PDL BioPharma, Inc seeks to provide return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotechnology, pharmaceutical and medical device industries. The firm has a market capitalization of $381.53 million, a price-to-earnings ratio of 26.04 and a beta of 0.52. The Company's segments include income generating assets and product sales.
Now the P/E of PDL BioPharma, Inc. stands at 26.48.
09/19/2014 - PDL BioPharma, Inc. was upgraded to " by analysts at Zacks. The company has its outstanding shares of 157.62 Million. 400,000 were reported by Park West Asset Limited Liability Company. Barrow Hanley Mewhinney Strauss Limited Liability Company stated it has 0% of its portfolio in PDL BioPharma Inc (NASDAQ:PDLI). Manufacturers Life The holds 0% or 118,480 shares in its portfolio.
For the Current Quarter, the growth estimate for PDL BioPharma, Inc.is 200%, while for the Next Quarter the stock growth estimate is -50%. Bancorp Of America Corporation De reported 119,846 shares. Alliancebernstein Ltd Partnership holds 0% or 257,322 shares. PDL BioPharma, Inc. has a 52-week low of 1.93 and a 52-week high of 3.77.
L & S Advisors Inc increased Amazon.Com (AMZN) stake by 123.44% reported in 2016Q4 SEC filing. 31,361 were reported by Savings Bank Of Montreal Can. Guggenheim Capital LLC owned approximately 0.05% of PDL BioPharma worth $189,000 at the end of the most recent quarter. First Citizens Bancshares & Tru stated it has 9,938 shares.
Returns and Valuations for PDL BioPharma, Inc.
Investors sentiment increased to 0.98 in 2016 Q4. Its down 0.11, from 1.18 in 2016Q3.
Since December 9, 2016, it had 0 buys, and 22 insider sales for $978.80 million activity. Rhumbline Advisers reported 205,782 shares. Mathes Co owns 12,143 shares. Highvista Strategies Ltd Liability has invested 0% in PDL BioPharma Inc (NASDAQ:PDLI). Strs Ohio has invested 0.22% in Aecom (NYSE:ACM). The stock increased 0.13% or $1.33 during the last trading session, reaching $995.95. Lombard Odier Asset (Europe) Ltd invested in 14,677 shares. Blackrock accumulated 57,411 shares. 225 are held by Hallmark Cap Mngmt Inc. Analyst rating score as published on FINVIZ are rated on a 1 to 5 scale. On Friday, June 10 the stock rating was initiated by William Blair with "Outperform". The company was maintained on Wednesday, August 12 by Credit Suisse. Deutsche Bank has "Hold" rating and $41 target. Canaccord Genuity downgraded it to "Hold" rating and $47 target in Monday, May 1 report. The rating was maintained by Benchmark with "Buy" on Friday, January 29. Zapolsky David had sold 1,010 shares worth $846,582 on Wednesday, February 15. A total volume of 3.39 million shares were traded versus to average volume of 1.84 million shares.
